Blog

Dr. Andre on Questions With Immunotherapy in Triple-Negative Breast Cancer – OncLive


OncLive

Dr. Andre on Questions With Immunotherapy in Triple-Negative Breast Cancer
OncLive
Fabrice André, MD, professor, Department of Medical Oncology, Institut Gustave Roussy, discusses the remaining questions with immunotherapy agents as potential therapy for patients with triple-negative breast cancer. Andre expanded on this in an

2018-03-09 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.